首页 | 本学科首页   官方微博 | 高级检索  
检索        

可溶性髓样细胞触发受体1对呼吸机相关性肺炎临床诊断价值的研究
引用本文:张婷婷,高宝安,陈世雄.可溶性髓样细胞触发受体1对呼吸机相关性肺炎临床诊断价值的研究[J].中国呼吸与危重监护杂志,2012,11(1):37-40.
作者姓名:张婷婷  高宝安  陈世雄
作者单位:三峡大学第一临床医学院-宜昌市中心人民医院呼吸内科 湖北宜昌443003
基金项目:湖北省教育厅自然科学研究项目中青年基金(编号:Q20111202)
摘    要:目的观察气管内抽吸物和血浆中可溶性髓样细胞触发受体1(sTREM-1)对呼吸机相关性肺炎(VAP)的临床诊断价值。方法纳入68例VAP患者为VAP组,50例接受机械通气但无VAP的患者为非VAP组,50例健康者为对照组。采用夹心酶联免疫吸附测定法(ELISA)检测受试者血浆sTREM-1、气管内抽吸物sTREM-1和血清高敏C反应蛋白(hs-CRP)浓度,计算各指标诊断VAP的敏感度和特异度。结果 VAP组治疗前血浆sTREM-1、气管内抽吸物sTREM-1水平均显著高于非VAP组(143.62±46.82)pg/mL比(68.56±16.24)pg/mL,(352.86±92.57)pg/mL比(126.21±42.28)pg/mL,P〈0.05],治疗第3 d和第7 d的血浆sTREM-1、气管内抽吸物sTREM-1水平显著降低(P〈0.05)。ROC曲线分析显示气管内抽吸物中sTREM-1浓度193.64 pg/mL可作为VAP合理的诊断浓度阈值(敏感度为93.84%,特异度为89.51%,ROC曲线下面积为0.912),其诊断价值优于血浆sTREM-1浓度(ROC曲线下面积为0.768)和血清hs-CRP浓度(ROC曲线下面积为0.704)。结论sTREM-1可作为VAP患者疗效判断的参考指标。气管内抽吸物中sTREM-1对VAP的诊断价值优于血浆sTREM-1和血清hs-CRP。

关 键 词:呼吸机相关性肺炎  可溶性髓样细胞触发受体1  机械通气  气管内抽吸物

Clinical Diagnostic Value of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Ventilator-Associated Pneumonia
ZHANG Ting-ting , GAO Bao-an , CHEN Shi-xiang.Clinical Diagnostic Value of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Ventilator-Associated Pneumonia[J].Chinese Journal of Respiratory and Critical Care Medicine,2012,11(1):37-40.
Authors:ZHANG Ting-ting  GAO Bao-an  CHEN Shi-xiang
Institution:.Department of Respiratory Medicine,First College of Clinical Medical Science of China Three Gorges University & Yichang Central People’s Hospital.Yichang,Hubei,443003,China
Abstract:Objective To evaluate the diagnostic value of soluble triggering receptor expressed on myeloid cells-1(sTREM-1) in endotracheal aspirate and plasma of patients with ventilator-associated pneumonia(VAP).Methods The consentration of sTREM-1 in plasma and endotracheal aspirate,and serum high-sensitivity C-reactive protein(hs-CRP) were measured by enzyme-linked immunosorbent assay(ELISA) in 68 patients with VAP(VAP group),50 patients underwent ventilation without VAP(non-VAP group),and 50 healthy individuals(control group).The sensitivity and specificity of each parameter were calculated.Results In the patients with VAP,sTREM-1 in plasma and endotracheal aspirate before treatment were significantly higher than that in the non-VAP group (143.62±46.82) pg/mL vs.(68.56±16.24)pg/mL,(352.86±92.57)pg/mL vs.(126.21±42.28)pg/mL,P<0.05];sTREM-1 in plasma and endotracheal aspirate on the 3rd and the 7th day during treatment were significantly decreased(P<0.05).By ROC analysis,the cut-off value of sTREM-1 in endotracheal aspirate were 193.64 pg/mL,with sensitivity and specificity of 93.84% and 89.51% respectively.The areas under ROC curve of sTREM-1 in endotracheal aspirate were 0.912.Clinical diagnostic value of sTREM-1 in endotracheal aspirate was better than plasma sTREM-1 and serum hs-CRP(areas under ROC curve were 0.768 and 0.704 respectively).Conclusions sTREM-1 may be helpful for evaluating the therapeutic effect in patients with VAP.The diagnostic value of sTREM-1 in endotracheal aspirate may be superior to plasma sTREM-1 and serum hs-CRP.
Keywords:Ventilator-associated pneumonia  Soluble triggering receptor expressed on myeloid cells-1  Mechanical ventilation  Endotracheal aspirate
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号